分散型臨床試験市場レポート：2023-2033

Decentralised Clinical Trials Market Report 2023-2033

レポート詳細分散型臨床試験市場レポート 2023-2033 ：本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなります。異業... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年4月17日	GBP4,500 部署ライセンスライセンス・価格情報・注文方法はこちら	278	278	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

分散型臨床試験市場レポート 2023-2033：本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなります。異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有益なレポートです。

COVID-19の大流行は、良くも悪くも、世界中のライフサイエンス組織の側に、現代の業界ではかつて目撃されたことのない規模の、前例のない適応を必要とした。パンデミックに対応して、バイオ製薬会社や医薬品開発業務受託機関（CRO）は、接触を最小限に抑え、患者の体験を向上させ、研究の進捗を維持する手段として、分散型またはデジタル臨床試験（DCT）を導入しました。デジタル臨床試験の文脈でバーチャル手法を活用することの利点は明らかであり、ライフサイエンス事業体にとって有利であることが証明されている。臨床試験の状況は、患者参加や治験施設での体験、コスト削減、データ統合の改善など、運用面での進歩によって変貌を遂げました。この変化により、DCTは臨床試験を実施するための有効なアプローチとして受け入れられています。

しかし、克服しなければならない障害もまだあります。従来の臨床試験の障害と、デジタルソリューションや分散型設計へのシフトから生じる障害の統合が、この新しい臨床試験のパラダイムを特徴づけています。分散型臨床試験の実施中に発生する課題を理解し、特定する責任は、バイオ医薬品企業や医薬品開発業務受託機関（CRO）にある。学術的な成功を収めるには、医療従事者や被験者に過度の負担をかけることなく、セキュリティや規制のプロトコルを守りながら、迅速な実行と簡略化が可能な使いやすい救済策を評価し、統合することが必要です。

マーケットリサーチレポートを購入する前に、どのような質問をするべきか？
- 分散型臨床試験市場はどのように進化しているのか？
- 分散型臨床試験市場を牽引し、抑制しているものは何か？
- 分散型臨床試験の各サブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める収益はどの程度になるのか？
- 2023年から2033年にかけて、分散型臨床試験の各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 主要な分散型臨床試験市場はマクロ経済ダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しはどうなっているのか？
- これらの主要企業の分散型臨床試験プロジェクトはどのようなものか？
- 2023年から2033年の間に、業界はどのように進化していくのか？分散型臨床試験プロジェクトが実施されることで、どのような影響があるのか？
現在および今後10年間に実施される分散型臨床試験プロジェクトにはどのような意味があるのか？
- 分散型臨床試験市場をさらに拡大するために、製品の商業化の必要性は高まっているのか？
- 分散型臨床試験市場はどこに向かっているのか、そして市場の最前線に立つためにはどうすればよいのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望は何か？

このことが、現在、そして今後10年間の分散型臨床試験市場にどのような影響を与えるかを見極める必要があります：

- 278ページにわたる本レポートでは、120の表と158のチャート/グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げており、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、分散型臨床試験市場が今後10年間にどのように発展するか、またCOVID-19の景気後退やバウンスの変化に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要です。

2033年までの予測やその他の分析により、商業的な展望を明らかにする。
- 今回の調査では、2033年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載しています。
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 定性的分析（市場力学、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。

本レポートでは、COVID-19が業界や貴社にどのような影響を与えるかについて、データ分析および貴重な知見を提供しています。COVID-19の4つの回収パターン、すなわち「V」、「L」、「W」、「U」の回収パターンとその影響について考察しています。

報告書の対象セグメント

適応症
- がん
- 循環器
- 免疫学
- 呼吸器
- その他

研究デザイン
- 介入研究
- 観察研究
- 拡張アクセス

エンドユーザー
- 製薬会社、バイオ製薬会社
- CROs
- その他

コンポーネント
- モバイルヘルスケア
- 遠隔医療
- 装着型デバイス
- Webベース技術
- その他

世界市場全体およびセグメントの収益予測に加え、5つの地域および23の主要国市場の収益予測も掲載しています：

北米
- 米国
- カナダ

欧州
- ドイツ
- イギリス
- フランス
- イタリア
- スペイン
- その他の欧州地域

アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- シンガポール
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他のラテンアメリカ地域

MEA
- GCC
- 南アフリカ
- その他のMEA地域

レポートには、分散型臨床試験市場の2023年から2033年にかけての主要企業のプロファイルと、これらの企業のこのセグメントに焦点を当てたものも含まれています。

主要企業と市場成長の可能性
・ CASTOR EDC
・ Clinical ink
・ CLOUDZBY, INC.
・ Dassault Systèmes (Medidata Solutions, Inc.)
・ ERGOMED PLC
・ FLORENCE HEALTHCARE INC.
・ ICON PLC
・ IQVIA Holdings, Inc.
・ Labcorp Drug Development
・ Medable, Inc.
・ Medrio Inc.
・ Oracle Corporation
・ Parexel International Corporation
・ PPD (Thermo Fisher Scientific Inc.)
・ Syneos Health

分散型臨床試験市場の世界全体の収益、2023年から2033年までの金額ベースで、市場は2023年に81億2500万米ドルを突破すると当研究所は計算しています。2033年まで収益が大きく伸びることが予測されます。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、常に先を行くことができるようになります。

分散型臨床試験市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
要約すると、当社の270ページ以上のレポートでは、以下の知識を提供します：

- 分散型臨床試験市場の2023年から2033年までの収益予測適応症、試験デザイン、エンドユーザー、構成要素の各予測を世界および地域レベルで掲載 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけます。

- 5つの地域と23の主要国市場の2033年までの収益予測 - 分散型臨床試験市場、2023年から2033年までの北米、欧州、アジア太平洋、ラテンアメリカ、MEAの市場の予測をご覧いただけます。また、アメリカ、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなどの著名な経済圏の市場も予測されています。

- 既存企業や市場参入を目指す企業の展望 - 2023年から2033年までの分散型臨床試験市場に関わる主要企業15社の企業プロファイルを含む。

独自の予測による定量・定性分析をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスとして情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性は低くなります。私たちの研究が、あなたの研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、分散型臨床試験市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1 レポートの概要
1.1 研究の目的
1.2 分散型臨床試験市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り：
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの妥当性確認
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場促進要因
3.2.1.1 分散型トライアルの優位性が市場成長を促進する
3.2.1.2 先端技術の採用拡大が市場成長を後押ししている
3.2.1.3 COVID-19パンデミックが分散型臨床試験の採用を促進する
3.2.1.4 新興国におけるCROの存在感の高まりが市場の成長を後押ししている
3.2.2 市場抑制要因
3.2.2.1 データセキュリティへの懸念が市場成長の妨げになる
3.2.2.2 複雑なサプライチェーンと製造が新規参入を制限する可能性
3.2.3 市場機会
3.2.3.1 分散型トライアル技術の進化が市場成長を後押しする
3.2.3.2 高度なクラウドプラットフォームの導入
3.2.3.3 政府からの支援は市場成長を促進すると予測される
3.2.3.4 市場プレイヤーによる合併、協定、買収は、市場で目撃された主要な傾向である。
3.3 COVID-19の影響度分析
3.4 分散型臨床試験市場のSWOT分析
3.4.1 強み
3.4.2 弱点
3.4.3 機会
3.4.4 脅威
3.5 ポーターのファイブフォース分析
3.5.1 サプライヤーのバーゲニングパワー
3.5.2 バイヤーのバーゲニングパワー
3.5.3 競争力のあるライバル企業
3.5.4 新規参入の脅威
3.5.5 代替え品の脅威
3.6 PEST分析
3.6.1 分散型臨床試験市場に影響を与える政治的要因
3.6.2 分散型臨床試験市場に影響を与える経済的要因
3.6.3 分散型臨床試験市場に影響を与える社会的要因
3.6.4 分散型臨床試験市場に影響を与える技術的要因

4 分散型臨床試験市場分析：適応症別
4.1 主要な調査結果
4.2 適応症別セグメント市場魅力度指数
4.3 薬効別分散型臨床試験市場規模の推定と予測
4.4 オンコロジー
4.4.1 地域別市場予測、2023〜2033年（US$ Mn、AGR %)
4.4.2 2023年・2033年の地域別市場シェア(%)
4.5 心臓血管
4.5.1 2023-2033年の地域別市場予測（US$ Mn, AGR %)
4.5.2 2023年および2033年の地域別市場シェア(%)
4.6 免疫学
4.6.1 2023-2033年地域別市場予測 (百万米ドル、AGR %)
4.6.2 2023年および2033年の地域別市場シェア（%)
4.7 呼吸器
4.7.1 2023-2033年の地域別市場予測（US$ Mn, AGR %)
4.7.2 2023年および2033年の地域別市場シェア(%)
4.8 その他
4.8.1 地域別市場予測、2023-2033年 (US$ Mn, AGR %)
4.8.2 地域別市場シェア、2023年＆2033年(%)

5 分散型臨床試験市場分析：研究デザイン別
5.1 主要な調査結果
5.2 研究デザインセグメント市場魅力度指数
5.3 分散型臨床試験市場の研究デザイン別市場規模の推定と予測
5.4 介入型
5.4.1 2023-2033年の地域別市場予測（US$ Mn, AGR %)
5.4.2 2023年・2033年の地域別市場シェア(%)
5.5 観察型
5.5.1 2023-2033年地域別市場予測（US$ Mn, AGR %)
5.5.2 地域別市場シェア、2023年＆2033年(%)
5.6 拡大アクセス
5.6.1 2023-2033年地域別市場予測（US$ Mn, AGR %)
5.6.2 地域別市場シェア、2023年＆2033年(%)

6 分散型臨床試験市場分析：エンドユーザー別
6.1 主要な調査結果
6.2 エンドユーザセグメント市場魅力度指数
6.3 エンドユーザー別分散型臨床試験市場規模推計・予測
6.4 製薬・バイオ医薬品企業
6.4.1 地域別市場予測、2023-2033年（US$ Mn, AGR %)
6.4.2 地域別市場シェア、2023年＆2033年(%)
6.5 CROs
6.5.1 地域別市場予測、2023-2033年（US$ Mn、AGR %)
6.5.2 地域別市場シェア、2023年＆2033年(%)
6.6 その他
6.6.1 地域別市場予測、2023-2033年（US$ Mn, AGR %)
6.6.2 地域別市場シェア、2023年＆2033年(%)

7 分散型臨床試験市場分析：コンポーネント別
7.1 主要な調査結果
7.2 コンポーネント・セグメント市場魅力度指数
7.3 分散型臨床試験市場のコンポーネント別市場規模の推定と予測
7.4 モバイルヘルスケア
7.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
7.4.2 2023年・2033年の地域別市場シェア(%)
7.5 遠隔医療
7.5.1 2023-2033年地域別市場予測（US$ Mn, AGR %)
7.5.2 2023年＆2033年地域別市場シェア(%)
7.6 着用型デバイス
7.6.1 2023-2033年地域別市場予測（US$ Mn, AGR %)
7.6.2 2023年＆2033年地域別市場シェア(%)
7.7 Webベース技術
7.7.1 地域別市場予測、2023年～2033年 (US$ Mn, AGR %)
7.7.2 2023年および2033年の地域別市場シェア(%)
7.8 その他
7.8.1 地域別市場予測、2023-2033年 (US$ Mn, AGR %)
7.8.2 地域別市場シェア、2023年＆2033年(%)

8 分散型臨床試験市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推計と予測

9 北米の分散型臨床試験市場分析
9.1 主要な調査結果
9.2 北米の分散型臨床試験市場魅力度指数
9.3 国別市場規模、2023年、2028年、2033年 (US$ Mn)
9.4 国別市場規模推定と予測、2023年〜2033年（US$ Mn)
9.5 適応症別市場規模の推定と予測、2023年〜2033年（US$ Mn)
9.6 試験デザイン別の市場規模の推定と予測、2023年〜2033年（US$ Mn)
9.7 エンドユーザー別の市場規模推定と予測、2023-2033年 (US$ Mn)
9.8 コンポーネント別の市場規模の推定と予測、2023年～2033年（US$ Mn)
9.9 米国の分散型臨床試験市場分析
9.9.1 主要プレイヤーの存在が米国分散型臨床試験市場を牽引する主要因となる
9.9.2 米国分散型臨床試験市場の成長は、主に研究開発費の増加とアウトソーシング活動に起因している。
9.10 カナダ分散型臨床試験市場の分析
9.10.1 カナダ市場は北米地域で最も速い成長を遂げると予想される
9.10.2 カナダでの共同研究の増加により細胞治療研究のインフラが整う

10 欧州の分散型臨床試験市場分析
10.1 主要な調査結果
10.2 欧州分散型臨床試験市場魅力度指数
10.3 国別市場規模、2023年、2028年、2033年 (US$ Mn)
10.4 国別市場規模推定と予測、2023年〜2033年（US$ Mn)
10.5 適応症別の市場規模の推定と予測、2023年〜2033年（US$ Mn)
10.6 試験デザイン別の市場規模の推定と予測、2023年-2033年（US$ Mn)
10.7 エンドユーザー別の市場規模推定と予測、2023年～2033年（US$ Mn)
10.8 コンポーネント別の市場規模の推定と予測、2023年～2033年（US$ Mn)
10.9 ドイツ分散型臨床試験市場分析
10.10 イギリス分散型臨床試験市場の分析
10.11 フランス分散型臨床試験市場の分析
10.12 イタリア分散型臨床試験市場の分析
10.13 スペイン分散型臨床試験市場の分析
10.14 ロシア分散型臨床試験市場の分析
10.15 その他の欧州の分散型臨床試験市場の分析

11 アジア太平洋地域の分散型臨床試験市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域の分散型臨床試験市場魅力度指数
11.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
11.4 国別市場規模推定と予測、2023年～2033年（US$ Mn)
11.5 適応症別市場規模の推定と予測、2023年～2033年（US$ Mn)
11.6 試験デザイン別の市場規模推定と予測、2023-2033年（US$ Mn)
11.7 エンドユーザー別の市場規模推定と予測、2023年〜2033年（US$ Mn)
11.8 コンポーネント別の市場規模の推定と予測、2023年～2033年（US$ Mn)
11.9 日本分散型臨床試験市場分析
11.10 中国分散型臨床試験市場分析
11.11 インドの分散型臨床試験市場分析
11.12 オーストラリアの分散型臨床試験市場分析
11.13 韓国分散型臨床試験市場分析
11.14 シンガポール分散型臨床試験市場分析
11.15 その他のアジア太平洋地域の分散型臨床試験市場の分析

12 ラテンアメリカの分散型臨床試験市場分析
12.1 主要な調査結果
12.2 ラテンアメリカの分散型臨床試験市場魅力度指数
12.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
12.4 国別市場規模の推定と予測、2023年～2033年（US$ Mn)
12.5 適応症別市場規模の推定と予測、2023年～2033年（US$ Mn)
12.6 試験デザイン別の市場規模推定と予測、2023-2033年（US$ Mn)
12.7 エンドユーザー別の市場規模推定と予測、2023年〜2033年（US$ Mn)
12.8 コンポーネント別の市場規模の推定と予測、2023年～2033年（US$ Mn)
12.9 ブラジル分散型臨床試験市場分析
12.10 メキシコの分散型臨床試験市場の分析
12.11 アルゼンチン分散型臨床試験市場の分析
12.12 コロンビアの分散型臨床試験市場の分析
12.13 その他のラテンアメリカの地域の分散型臨床試験市場の分析

13 MEAの分散型臨床試験市場分析
13.1 主要な調査結果
13.2 MEAの分散型臨床試験市場魅力度指数
13.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
13.4 国別市場規模推定と予測、2023年～2033年（US$ Mn)
13.5 適応症別市場規模の推定と予測、2023年～2033年（US$ Mn)
13.6 試験デザイン別の市場規模推定と予測、2023-2033年（US$ Mn)
13.7 エンドユーザー別の市場規模推定と予測、2023年〜2033年（US$ Mn)
13.8 コンポーネント別の市場規模の推定と予測、2023年～2033年（US$ Mn)
13.9 GCC分散型臨床試験市場の分析
13.10 南アフリカの分散型臨床試験市場の分析
13.11 その他のMEA地域の分散型臨床試験市場の分析

14 会社概要
14.1 IQVIA Holdings, Inc.
14.1.1 企業スナップショット
14.1.2 会社概要
14.1.3 財務分析
14.1.3.1 純収益、2015年～2022年
14.1.3.2 地域別市場占有率、2022年
14.1.4 製品ベンチマーキング
14.1.5 戦略的な展望
14.2 ICON PLC
14.2.1 企業スナップショット
14.2.2 会社概要
14.2.3 財務分析
14.2.3.1 純収益、2015年～2022年
14.2.3.2 地域別市場占有率、2022年
14.2.4 製品ベンチマーキング
14.2.5 戦略的な展望
14.3 Labcorp Drug Development
14.3.1 企業スナップショット
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2015-2022年
14.3.4 製品のベンチマーキング
14.3.5 戦略的な展望
14.4 Dassault Systèmes (Medidata Solutions, Inc.)
14.4.1 企業スナップショット
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収益、2015年～2022年
14.4.3.2 地域別市場占有率、2022年
14.4.4 製品のベンチマーキング
14.4.5 戦略的な展望
14.5 Oracle Corporation
14.5.1 企業スナップショット
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収益、2015年～2022年
14.5.3.2 地域別市場占有率、2022年
14.5.4 製品のベンチマーキング
14.5.5 戦略的な展望
14.6 Parexel International Corporation
14.6.1 企業スナップショット
14.6.2 会社概要
14.6.3 製品ベンチマーク
14.6.4 戦略的な展望
14.7 Medrio Inc.
14.7.1 企業スナップショット
14.7.2 会社概要
14.7.3 ベンチマーキング製品
14.7.4 戦略的な展望
14.8 Medable, Inc.
14.8.1 企業スナップショット
14.8.2 会社概要
14.8.3 ベンチマーキング製品
14.8.4 戦略的な展望
14.9 Clinical ink
14.9.1 企業スナップショット
14.9.2 会社概要
14.9.3 製品ベンチマーク
14.9.4 戦略的な展望
14.10 FLORENCE HEALTHCARE INC.
14.10.1 企業スナップショット
14.10.2 会社概要
14.10.3 ベンチマーキング製品
14.10.4 戦略的な展望
14.11 Syneos Health
14.11.1 企業スナップショット
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収益、2015年〜2022年
14.11.3.2 地域別市場占有率、2022年
14.11.4 製品のベンチマーキング
14.11.5 戦略的な展望
14.12 PPD（Thermo Fisher Scientific Inc.）
14.12.1 企業スナップショット
14.12.2 会社概要
14.12.3 財務分析
14.12.3.1 純収益、2016-2020年
14.12.4 製品のベンチマーキング
14.12.5 戦略的な展望
14.13 CASTOR EDC
14.13.1 企業スナップショット
14.13.2 会社概要
14.13.3 製品ベンチマーク
14.13.4 戦略的な展望
14.14 CLOUDZBY, INC.
14.14.1 企業スナップショット
14.14.2 会社概要
14.14.3 製品ベンチマーク
14.14.4 戦略的な展望
14.15 ERGOMED PLC
14.15.1 企業スナップショット
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純収益、2016年〜2020年
14.15.3.2 地域別市場占有率、2022年
14.15.4 製品のベンチマーキング
14.15.5 戦略的な展望

15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場関係者への提言

表の一覧
Table 1 Decentralised Clinical Trials Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cardiovascular Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Interventional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Observational Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Expanded Access Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Mobile Healthcare Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Telemedicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Wearable Devices Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Web-based Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Decentralised Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 U.S. Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Canada Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Germany Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 France Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Italy Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Spain Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Russia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Rest of Europe Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Japan Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 China Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 India Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Australia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 South Korea Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Singapore Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Brazil Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Mexico Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Argentina Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Colombia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 MEA Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 GCC Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 South Africa Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Rest of MEA Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 IQVIA Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IQVIA Holdings, Inc.: Product Benchmarking
Table 78 IQVIA Holdings, Inc.: Strategic Outlook
Table 79 ICON PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 ICON PLC: Product Benchmarking
Table 81 ICON PLC: Strategic Outlook
Table 82 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Labcorp Drug Development: Product Benchmarking
Table 84 Labcorp Drug Development: Strategic Outlook
Table 85 Dassault Systèmes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dassault Systèmes: Product Benchmarking
Table 87 Dassault Systèmes: Strategic Outlook
Table 88 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Oracle Corporation: Product Benchmarking
Table 90 Oracle Corporation: Strategic Outlook
Table 91 Paraxel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Paraxel International Corporation: Product Benchmarking
Table 93 Paraxel International Corporation: Strategic Outlook
Table 94 Medrio Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Medrio Inc.: Product Benchmarking
Table 96 Medrio Inc.: Strategic Outlook
Table 97 Medable, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Medable Inc.: Product Benchmarking
Table 99 Medable Inc.: Strategic Outlook
Table 100 Clinical ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Clinical ink: Product Benchmarking
Table 102 Clinical ink: Strategic Outlook
Table 103 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Florence Healthcare, Inc.: Product Benchmarking
Table 105 Florence Healthcare, Inc.: Strategic Outlook
Table 106 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Syneos Health: Product Benchmarking
Table 108 Syneos Health: Strategic Outlook
Table 109 PPD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 PPD: Product Benchmarking
Table 111 PPD: Strategic Outlook
Table 112 CASTOR EDC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 CASTOR EDC: Product Benchmarking
Table 114 CASTOR EDC: Strategic Outlook
Table 115 CLOUDZBY, INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 CLOUDZBY, INC.: Product Benchmarking
Table 117 CLOUDZBY, INC.: Strategic Outlook
Table 118 Ergomed PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Ergomed PLC: Product Benchmarking
Table 120 Ergomed PLC: Strategic Outlook

図の一覧
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by Component: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market Attractiveness Index by Region
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 9 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 10 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 11 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 12 Decentralised Clinical Trials Market: SWOT Analysis
Figure 13 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 14 Decentralised Clinical Trials Market Attractiveness Index by Indication
Figure 15 Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 16 Decentralised Clinical Trials Market Share Forecast by Indication, 2023, 2028, 2033 (%)
Figure 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Cardiovascular Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Cardiovascular Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Respiratory Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Decentralised Clinical Trials Market Attractiveness Index by Indication
Figure 28 Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 29 Decentralised Clinical Trials Market Share Forecast by Study Design, 2023, 2028, 2033 (%)
Figure 30 Interventional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Interventional Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Observational Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Observational Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Expanded Access Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Expanded Access Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Decentralised Clinical Trials Market Attractiveness Index by End-users
Figure 37 Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 38 Decentralised Clinical Trials Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 39 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 CROs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Decentralised Clinical Trials Market Attractiveness Index by Component
Figure 46 Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 47 Decentralised Clinical Trials Market Share Forecast by Component, 2023, 2028, 2033 (%)
Figure 48 Mobile Healthcare Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 49 Mobile Healthcare Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Telemedicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 51 Telemedicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Wearable Devices Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Wearable Devices Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Web-based Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Web-based Technology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Decentralised Clinical Trials Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 59 Decentralised Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 60 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %)
Figure 61 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 62 North America Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 63 North America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 64 North America Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 65 North America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 66 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 67 North America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 68 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 69 North America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 70 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 71 North America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 72 North America Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 73 U.S. Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Canada Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 76 Europe Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 77 Europe Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 78 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 79 Europe Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 81 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 83 Europe Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Europe Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 86 Europe Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 87 Germany Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 UK Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 France Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Italy Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Spain Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Russia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 Rest of Europe Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 94 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 95 Asia Pacific Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 96 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 97 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 98 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 100 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 102 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 106 Japan Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 China Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 India Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Australia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 South Korea Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Singapore Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 112 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 114 Latin America Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 115 Latin America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 116 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 117 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 119 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 120 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 121 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 122 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 123 Latin America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 124 Latin America Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 125 Brazil Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Mexico Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Argentina Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 Colombia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 131 MEA Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 132 MEA Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 133 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 MEA Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 136 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 138 MEA Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 140 MEA Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 142 GCC Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 South Africa Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of MEA Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 IQVIA Holdings Inc.: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 146 IQVIA Holdings Inc.: Regional Market Shares, 2022
Figure 147 ICON PLC: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 148 ICON PLC: Regional Market Shares, 2022
Figure 149 Labcorp Drug Development (Covance, Inc.): Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 150 Dassault Systèmes: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 151 Dassault Systèmes: Regional Market Shares, 2022
Figure 152 Oracle Corporation: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 153 Oracle Corporation: Regional Market Shares, 2022
Figure 154 Syneos Health: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 155 Syneos Health: Regional Market Shares, 2022
Figure 156 PPD: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 157 Ergomed PLC: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 158 Ergomed PLC: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents

Summary

Report Details

The Decentralised Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The COVID-19 pandemic necessitated unprecedented adaptation on the part of life sciences organisations worldwide, for better or for worse, on a scale that has not been witnessed before in the contemporary industry. In response to the pandemic, biopharmaceutical companies and contract research organisations (CROs) have implemented decentralised or digital clinical trials (DCTs) as a means of minimising contact, enhancing the patient experience, and maintaining the progress of studies. The advantages of utilising virtual methods in the context of digital clinical trials are evident and have proven to be advantageous for life science entities. The clinical trial landscape has undergone a transformation with advancements in operational aspects such as patient engagement and site experience, cost reduction, and improved data integration. This shift has resulted in the acceptance of DCTs as a viable approach for conducting clinical studies.

Nevertheless, there are still obstacles to be overcome. The integration of conventional clinical trial obstacles with those arising from the shift towards digital solutions and decentralised designs characterises this novel clinical trial paradigm. The responsibility lies with biopharmaceutical companies and Contract Research Organizations (CROs) to comprehend and identify the challenges that arise during the implementation of a decentralised clinical trial. The achievement of academic success is contingent upon the assessment and integration of user-friendly remedies that can be expeditiously executed and simplified without imposing undue burden on healthcare professionals and recipients, all while upholding security and regulatory protocols.

What Questions Should You Ask before Buying a Market Research Report?
• How is the decentralised clinical trials market evolving?
• What is driving and restraining the decentralised clinical trials market?
• How will each decentralised clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each decentralised clinical trials submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading decentralised clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the decentralised clinical trials projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
decentralised clinical trials projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the decentralised clinical trials market?
• Where is the decentralised clinical trials market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the decentralised clinical trials market today, and over the next 10 years:
• Our 278-page report provides 120 tables and 158 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the decentralised clinical trials market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Indication
• Oncology
• Cardiovascular
• Immunology
• Respiratory
• Others

Study Design
• Interventional
• Observational
• Expanded Access

End-users
• Pharmaceutical and Biopharmaceutical Companies
• CROs
• Others

Component
• Mobile Healthcare
• Telemedicine
• Wearable Devices
• Web-based Technology
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Decentralised Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• CASTOR EDC
• Clinical ink
• CLOUDZBY, INC.
• Dassault Systèmes (Medidata Solutions, Inc.)
• ERGOMED PLC
• FLORENCE HEALTHCARE INC.
• ICON PLC
• IQVIA Holdings, Inc.
• Labcorp Drug Development
• Medable, Inc.
• Medrio Inc.
• Oracle Corporation
• Parexel International Corporation
• PPD (Thermo Fisher Scientific Inc.)
• Syneos Health

Overall world revenue for Decentralised Clinical Trials Market, 2023 to 2033 in terms of value the market will surpass US$8,125.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Decentralised Clinical Trials Market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Decentralised Clinical Trials Market, 2023 to 2033 Market, with forecasts for indication, study design, end-users, and component, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 23 key national markets – See forecasts for the Decentralised Clinical Trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Decentralised Clinical Trials Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Decentralised Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Decentralised Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Advantages of Decentralised Trials Driving Market Growth
3.2.1.2 Growing Adoption of Advanced Technologies is Boosting the Market Growth
3.2.1.3 COVID-19 Pandemic is driving the Adoption of Decentralised Clinical Trials
3.2.1.4 Rising Presence of CROs in Emerging Market is Boosting the Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Data Security Concerns Hinders the Market Growth
3.2.2.2 Complex Supply Chain and Manufacturing Could limit the Entry of New Players
3.2.3 Market Opportunities
3.2.3.1 Evolution of Decentralised Trials Technologies is Projected to Boost the Market Growth
3.2.3.2 Introduction of Advanced Cloud Platform
3.2.3.3 Support from Government is Estimated to Propel Market Growth
3.2.3.4 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.3 COVID-19 Impact Analysis
3.4 SWOT Analysis for Decentralised Clinical Trials Market
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Supplier
3.5.2 Bargaining Power of Buyer
3.5.3 Competitive Rivalry
3.5.4 Threat of New Entrants
3.5.5 Threat of Substitutes
3.6 PEST Analysis
3.6.1 Political Factors Impacting Decentralised Clinical Trials Market
3.6.2 Economic Factors Impacting Decentralised Clinical Trials Market
3.6.3 Social Factors Impacting Decentralised Clinical Trials Market
3.6.4 Technological Factors Impacting Decentralised Clinical Trials Market

4 Decentralised Clinical Trials Market Analysis by Indication
4.1 Key Findings
4.2 Indication Segment: Market Attractiveness Index
4.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
4.4 Oncology
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Cardiovascular
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Immunology
4.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Respiratory
4.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Others
4.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Decentralised Clinical Trials Market Analysis by Study Design
5.1 Key Findings
5.2 Study Design Segment: Market Attractiveness Index
5.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
5.4 Interventional
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Observational
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Expanded Access
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Decentralised Clinical Trials Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
6.4 Pharmaceutical and Biopharmaceutical Companies
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 CROs
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Others
6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Decentralised Clinical Trials Market Analysis by Component
7.1 Key Findings
7.2 Component Segment: Market Attractiveness Index
7.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Component
7.4 Mobile Healthcare
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Telemedicine
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Wearable Devices
7.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Web-based Technology
7.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Others
7.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Decentralised Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Decentralised Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America Decentralised Clinical Trials Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
9.5 Market Size Estimation and Forecast by Indication, 2023-2033 (US$ Mn)
9.6 Market Size Estimation and Forecast by Study Design, 2023-2033 (US$ Mn)
9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
9.8 Market Size Estimation and Forecast by Component, 2023-2033 (US$ Mn)
9.9 U.S. Decentralised Clinical Trials Market Analysis
9.9.1 Presence of Leading Players is a Major factor driving the U. S. Decentralised Clinical Trials Market
9.9.2 U. S. Decentralised Clinical Trials Market Growth is Primarily Attributable to Growing R&D Expenditure and Outsourcing Activities
9.10 Canada Decentralised Clinical Trials Market Analysis
9.10.1 Canada Market Anticipated to Witness the Fastest Growth in the North America Region
9.10.2 Growing Canadian research collaborations determined to Provide Infrastructure for Cell-Based Therapy Research

10 Europe Decentralised Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe Decentralised Clinical Trials Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Indication, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Study Design, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Component, 2023-2033 (US$ Mn)
10.9 Germany Decentralised Clinical Trials Market Analysis
10.10 UK Decentralised Clinical Trials Market Analysis
10.11 France Decentralised Clinical Trials Market Analysis
10.12 Italy Decentralised Clinical Trials Market Analysis
10.13 Spain Decentralised Clinical Trials Market Analysis
10.14 Russia Decentralised Clinical Trials Market Analysis
10.15 Rest of Europe Decentralised Clinical Trials Market Analysis

11 Asia Pacific Decentralised Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Indication, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Study Design, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Component, 2023-2033 (US$ Mn)
11.9 Japan Decentralised Clinical Trials Market Analysis
11.10 China Decentralised Clinical Trials Market Analysis
11.11 India Decentralised Clinical Trials Market Analysis
11.12 Australia Decentralised Clinical Trials Market Analysis
11.13 South Korea Decentralised Clinical Trials Market Analysis
11.14 Singapore Decentralised Clinical Trials Market Analysis
11.15 Rest of Asia Pacific Decentralised Clinical Trials Market Analysis

12 Latin America Decentralised Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America Decentralised Clinical Trials Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Indication, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Study Design, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Component, 2023-2033 (US$ Mn)
12.9 Brazil Decentralised Clinical Trials Market Analysis
12.10 Mexico Decentralised Clinical Trials Market Analysis
12.11 Argentina Decentralised Clinical Trials Market Analysis
12.12 Colombia Decentralised Clinical Trials Market Analysis
12.13 Rest of Latin America Decentralised Clinical Trials Market Analysis

13 MEA Decentralised Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA Decentralised Clinical Trials Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Indication, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Study Design, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Component, 2023-2033 (US$ Mn)
13.9 GCC Decentralised Clinical Trials Market Analysis
13.10 South Africa Decentralised Clinical Trials Market Analysis
13.11 Rest of MEA Decentralised Clinical Trials Market Analysis

14 Company Profiles
14.1 IQVIA Holdings, Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2015-2022
14.1.3.2 Regional Market Shares, 2022
14.1.4 Product Benchmarking
14.1.5 Strategic Outlook
14.2 ICON PLC
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2015-2022
14.2.3.2 Regional Market Shares, 2022
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Labcorp Drug Development
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2015-2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Dassault Systèmes (Medidata Solutions, Inc.)
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2015-2022
14.4.3.2 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Oracle Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2015-2022
14.5.3.2 Regional Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Parexel International Corporation
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product Benchmarking
14.6.4 Strategic Outlook
14.7 Medrio Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Strategic Outlook
14.8 Medable, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Clinical ink
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Strategic Outlook
14.10 FLORENCE HEALTHCARE INC.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 Syneos Health
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2015-2022
14.11.3.2 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 PPD (Thermo Fisher Scientific Inc.)
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2016-2020
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 CASTOR EDC
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 CLOUDZBY, INC.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.14.4 Strategic Outlook
14.15 ERGOMED PLC
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2016-2020
14.15.3.2 Regional Market Shares, 2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Decentralised Clinical Trials Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Decentralised Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cardiovascular Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Interventional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Observational Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Expanded Access Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Mobile Healthcare Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Telemedicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Wearable Devices Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Web-based Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Decentralised Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 U.S. Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Canada Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Germany Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 France Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Italy Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Spain Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Russia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Rest of Europe Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Japan Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 China Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 India Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Australia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 South Korea Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Singapore Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Brazil Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Mexico Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Argentina Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Colombia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 MEA Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 GCC Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 South Africa Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Rest of MEA Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 IQVIA Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IQVIA Holdings, Inc.: Product Benchmarking
Table 78 IQVIA Holdings, Inc.: Strategic Outlook
Table 79 ICON PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 ICON PLC: Product Benchmarking
Table 81 ICON PLC: Strategic Outlook
Table 82 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Labcorp Drug Development: Product Benchmarking
Table 84 Labcorp Drug Development: Strategic Outlook
Table 85 Dassault Systèmes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dassault Systèmes: Product Benchmarking
Table 87 Dassault Systèmes: Strategic Outlook
Table 88 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Oracle Corporation: Product Benchmarking
Table 90 Oracle Corporation: Strategic Outlook
Table 91 Paraxel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Paraxel International Corporation: Product Benchmarking
Table 93 Paraxel International Corporation: Strategic Outlook
Table 94 Medrio Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Medrio Inc.: Product Benchmarking
Table 96 Medrio Inc.: Strategic Outlook
Table 97 Medable, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Medable Inc.: Product Benchmarking
Table 99 Medable Inc.: Strategic Outlook
Table 100 Clinical ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Clinical ink: Product Benchmarking
Table 102 Clinical ink: Strategic Outlook
Table 103 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Florence Healthcare, Inc.: Product Benchmarking
Table 105 Florence Healthcare, Inc.: Strategic Outlook
Table 106 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Syneos Health: Product Benchmarking
Table 108 Syneos Health: Strategic Outlook
Table 109 PPD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 PPD: Product Benchmarking
Table 111 PPD: Strategic Outlook
Table 112 CASTOR EDC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 CASTOR EDC: Product Benchmarking
Table 114 CASTOR EDC: Strategic Outlook
Table 115 CLOUDZBY, INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 CLOUDZBY, INC.: Product Benchmarking
Table 117 CLOUDZBY, INC.: Strategic Outlook
Table 118 Ergomed PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Ergomed PLC: Product Benchmarking
Table 120 Ergomed PLC: Strategic Outlook

List of Figures
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by Component: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market Attractiveness Index by Region
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 9 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 10 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 11 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 12 Decentralised Clinical Trials Market: SWOT Analysis
Figure 13 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 14 Decentralised Clinical Trials Market Attractiveness Index by Indication
Figure 15 Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 16 Decentralised Clinical Trials Market Share Forecast by Indication, 2023, 2028, 2033 (%)
Figure 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Cardiovascular Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Cardiovascular Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Respiratory Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Decentralised Clinical Trials Market Attractiveness Index by Indication
Figure 28 Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 29 Decentralised Clinical Trials Market Share Forecast by Study Design, 2023, 2028, 2033 (%)
Figure 30 Interventional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Interventional Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Observational Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Observational Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Expanded Access Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Expanded Access Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Decentralised Clinical Trials Market Attractiveness Index by End-users
Figure 37 Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 38 Decentralised Clinical Trials Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 39 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 CROs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Decentralised Clinical Trials Market Attractiveness Index by Component
Figure 46 Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 47 Decentralised Clinical Trials Market Share Forecast by Component, 2023, 2028, 2033 (%)
Figure 48 Mobile Healthcare Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 49 Mobile Healthcare Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Telemedicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 51 Telemedicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Wearable Devices Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Wearable Devices Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Web-based Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Web-based Technology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Decentralised Clinical Trials Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 59 Decentralised Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 60 Decentralised Clinical Trials Market by Region, 2023-2033 (US$ Mn, AGR %)
Figure 61 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 62 North America Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 63 North America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 64 North America Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 65 North America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 66 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 67 North America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 68 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 69 North America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 70 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 71 North America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 72 North America Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 73 U.S. Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Canada Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 76 Europe Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 77 Europe Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 78 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 79 Europe Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 81 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 83 Europe Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Europe Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 86 Europe Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 87 Germany Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 UK Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 France Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Italy Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Spain Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Russia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 Rest of Europe Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 94 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 95 Asia Pacific Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 96 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 97 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 98 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 100 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 102 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 106 Japan Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 China Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 India Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Australia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 South Korea Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Singapore Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 112 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 114 Latin America Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 115 Latin America Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 116 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 117 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 119 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 120 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 121 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 122 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 123 Latin America Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 124 Latin America Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 125 Brazil Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Mexico Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Argentina Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 Colombia Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 131 MEA Decentralised Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 132 MEA Decentralised Clinical Trials Market Forecast by Country, 2023-2033 (US$ million)
Figure 133 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 MEA Decentralised Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 136 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2023 & 2033 (%)
Figure 138 MEA Decentralised Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 140 MEA Decentralised Clinical Trials Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Share Forecast by Component, 2023 & 2033 (%)
Figure 142 GCC Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 South Africa Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of MEA Decentralised Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 IQVIA Holdings Inc.: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 146 IQVIA Holdings Inc.: Regional Market Shares, 2022
Figure 147 ICON PLC: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 148 ICON PLC: Regional Market Shares, 2022
Figure 149 Labcorp Drug Development (Covance, Inc.): Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 150 Dassault Systèmes: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 151 Dassault Systèmes: Regional Market Shares, 2022
Figure 152 Oracle Corporation: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 153 Oracle Corporation: Regional Market Shares, 2022
Figure 154 Syneos Health: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 155 Syneos Health: Regional Market Shares, 2022
Figure 156 PPD: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 157 Ergomed PLC: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 158 Ergomed PLC: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（healthcare）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

分散型臨床試験市場レポート：2023-2033

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（healthcare）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?